Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.7%

60 terminated/withdrawn out of 1049 trials

Success Rate

91.0%

+4.4% vs industry average

Late-Stage Pipeline

9%

95 trials in Phase 3/4

Results Transparency

2%

14 of 607 completed trials have results

Key Signals

124 recruiting14 with results42 terminated18 withdrawn

Enrollment Performance

Analytics

N/A
573(78.7%)
Phase 4
56(7.7%)
Phase 3
39(5.4%)
Phase 2
39(5.4%)
Phase 1
15(2.1%)
Early Phase 1
6(0.8%)
728Total
N/A(573)
Phase 4(56)
Phase 3(39)
Phase 2(39)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1049)

Showing 20 of 1049 trials
NCT07287358Not ApplicableNot Yet Recruiting

Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II

Role: lead

NCT05063149Phase 3Recruiting

Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.

Role: collaborator

NCT07805057Not ApplicableRecruiting

Magnetic Brain Stimulation in Small Fiber Neuropathy

Role: lead

NCT07677098Not ApplicableNot Yet Recruiting

Effects of Protein Type and Mineral Form on Amino Acid Availability

Role: lead

NCT07105280Not ApplicableNot Yet Recruiting

Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease

Role: collaborator

NCT05037461Not ApplicableActive Not Recruiting

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

Role: collaborator

NCT02271828Not ApplicableCompleted

Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy

Role: lead

NCT07752225Not ApplicableNot Yet Recruiting

Long-term Effects of Avocado Consumption on Health in Pre-diabetic Individuals

Role: lead

NCT06923475Phase 2Recruiting

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Role: collaborator

NCT07641985Not ApplicableRecruiting

Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients

Role: lead

NCT05911451Not ApplicableCompleted

Optimizing Access Surgery In Senior Hemodialysis Patients

Role: lead

NCT05900271Not ApplicableRecruiting

Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

Role: collaborator

NCT07715955Not ApplicableRecruiting

Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity

Role: lead

NCT07399886Not ApplicableRecruiting

Plant-based Versus Animal-based Oral Nutritional Supplements

Role: collaborator

NCT07743762Not ApplicableNot Yet Recruiting

Percutaneous Versus EUS-guided Drainage of Symptomatic Fluid Collections After Left Pancreatectomy

Role: collaborator

NCT07402343Phase 2Recruiting

Tarlatamab for SCLC Brain Metastases

Role: lead

NCT07730242Not ApplicableNot Yet Recruiting

Beat-to-beat Evaluation of Atrial Pacing to Test Fluid Responsiveness

Role: lead

NCT07422220Not ApplicableRecruiting

Long-Term Effects of Walnut Consumption on Brain Function

Role: lead

NCT07717437Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Role: lead

NCT06888817Phase 3Recruiting

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Role: collaborator